Literature DB >> 9566717

Sonodynamically-induced cell damage with fluorinated anthracycline derivative, FAD104.

N Yumita1, S Umemura, M Kaneuchi, Y Okano, N Magario, M Ishizaki, K Shimizu, Y Sano, K Umemura, R Nishigaki.   

Abstract

The ultrasonically-induced in vitro cell damaging effect of fluorine-containing anthracycline derivative (FAD104) was investigated. Sarcoma 180 cells suspended in air-saturated PBS were exposed to ultrasound for up to 60 s in the presence and absence of FAD104. The rate of inducing cell damage with ultrasound was doubled with 80 microM FAD104, while no cell damage was observed with FAD104 alone. This enhancement was significantly inhibited by histidine, which may suggest a sonochemical mechanism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566717     DOI: 10.1016/s0304-3835(97)00515-6

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

Review 1.  Sound waves and antineoplastic drugs: The possibility of an enhanced combined anticancer therapy.

Authors:  Loreto B Feril; Takashi Kondo; Shin-Ichiro Umemura; Katsuro Tachibana; Angelo H Manalo; Peter Riesz
Journal:  J Med Ultrason (2001)       Date:  2002-12       Impact factor: 1.314

2.  Evaluation of fractionated and repeated sonodynamic therapy by using dual frequency for murine model of breast adenocarcinoma.

Authors:  Mahboobeh Alamolhoda; Manijhe Mokhtari-Dizaji
Journal:  J Ther Ultrasound       Date:  2015-06-24

3.  IR-780 Dye as a Sonosensitizer for Sonodynamic Therapy of Breast Tumor.

Authors:  Yekuo Li; Qunfang Zhou; Zhiting Deng; Min Pan; Xin Liu; Junru Wu; Fei Yan; Hairong Zheng
Journal:  Sci Rep       Date:  2016-05-13       Impact factor: 4.379

Review 4.  Using the Promise of Sonodynamic Therapy in the Clinical Setting against Disseminated Cancers.

Authors:  Matthew Trendowski
Journal:  Chemother Res Pract       Date:  2015-08-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.